FDA issues new labeling for gadolinium contrast

The U.S. Food and Drug Administration (FDA) in April published revised product...Read more on AuntMinnie.comRelated Reading: Japan adopts new gadolinium use restrictions Safety issues linger over gadolinium-based contrast agents Norris lawsuit puts personal face on gadolinium debate Evidence mounts: Use macrocyclic GBCAs in pediatric MRI FDA panel votes to add retention warning to GBCA labels
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news